|Title:||Adjustment in the clinical practice of treat-to-target guidelines for rheumatoid arthritis: Results of the ToARCan study||Authors:||Naranjo, Antonio
Hernández-Beriaín, José Ángel
Martín, José Adán
|Keywords:||Remission Induction Cohort
|Issue Date:||2016||Publisher:||1699-258X||Journal:||Reumatologia Clinica||Abstract:||Objective:To analyze compliance with t2t clinical practice guidelines.Methods:Cross-sectional observational study in consecutive patients with rheumatoid arthritis (RA) in 5 hospitals in the Canary Islands. Patients filled out activity scales, HAQ and answered the question of whether the doctor had explained the treatment target. The rheumatologist also collected: visits in the past year, use of activity indices and HAQ, DAS28 of current visit and date of the next visit. The percentage of compliance to indicators based on the t2t recommendations (R) 1, 3, 5-7 and 10 was analyzed.Results:A total of 343 patients were recruited, 77% female, mean age 57, RA duration of 10 years. Median visits in the last year were 3 and mean time between last and current visit was 5.6 months. A total of 93% of the patients were treated with DMARDs and 44% were in remission by DAS (R1). In the previous visit, documented joint count was present in 85%, a HAQ in 19%, patient VAS in 41%, and a DAS28 in 35% of the patients (R6). The next visit was scheduled at an average of 4.3 months (R5). In 64% of patients with DAS28> 3.2 a visit between one and 3 months was scheduled (R5). A total of 96% of patients said they had been informed of the treatment target (R10). Variability between centers existed but was moderate. The only factor determining the performance of a DAS28 in the last visit was the patient's center of origin.Conclusion:The Canary Island centers studied achieved high levels of remission and low activity in their patients. The performance of composite indices and follow-up frequency recommended by the t2t are met, although there is room for improvement. (C) 2014 Elsevier Espana, S.L.U.y Sociedad Espanola de Reumatologia y Colegio Mexicano de Reumatologia. All rights reserved.||URI:||http://hdl.handle.net/10553/50097||ISSN:||1699-258X||DOI:||10.1016/j.reuma.2015.03.003||Source:||Reumatologia Clinica[ISSN 1699-258X],v. 12, p. 34-38|
|Appears in Collections:||Artículos|
checked on May 3, 2021
Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.